Danaher Corporation (NYSE:DHR – Free Report) – Equities researchers at Leerink Partnrs cut their FY2025 earnings estimates for Danaher in a report released on Tuesday, October 21st. Leerink Partnrs analyst P. Souda now expects that the conglomerate will earn $7.70 per share for the year, down from their previous forecast of $7.76. The consensus estimate for Danaher’s current full-year earnings is $7.63 per share. Leerink Partnrs also issued estimates for Danaher’s Q4 2025 earnings at $2.13 EPS, Q1 2026 earnings at $2.10 EPS, Q4 2026 earnings at $2.35 EPS and FY2026 earnings at $8.35 EPS.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.93%. The business had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. During the same period in the prior year, the business posted $1.71 earnings per share. The company’s revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS.
Check Out Our Latest Report on DHR
Danaher Stock Performance
NYSE DHR opened at $218.06 on Thursday. The company has a 50-day simple moving average of $202.24 and a two-hundred day simple moving average of $197.73. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher has a 12-month low of $171.00 and a 12-month high of $260.88. The firm has a market cap of $156.14 billion, a price-to-earnings ratio of 44.96, a PEG ratio of 3.20 and a beta of 0.77.
Danaher Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio is presently 27.23%.
Insider Activity at Danaher
In other news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 11.10% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Danaher
Large investors have recently bought and sold shares of the business. White Pine Capital LLC lifted its stake in shares of Danaher by 1.4% during the 2nd quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock worth $690,000 after purchasing an additional 49 shares during the last quarter. Boyd Watterson Asset Management LLC OH lifted its stake in shares of Danaher by 2.1% during the 2nd quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock worth $499,000 after purchasing an additional 51 shares during the last quarter. Hills Bank & Trust Co lifted its stake in shares of Danaher by 0.3% during the 1st quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate’s stock worth $3,693,000 after purchasing an additional 53 shares during the last quarter. Worth Financial Advisory Group LLC lifted its stake in shares of Danaher by 4.6% during the 2nd quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock worth $236,000 after purchasing an additional 53 shares during the last quarter. Finally, Howard Capital Management Group LLC lifted its stake in shares of Danaher by 4.8% during the 3rd quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate’s stock worth $230,000 after purchasing an additional 53 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- What is the Nikkei 225 index?
- Archer’s Recent String of Victories Signals a New Phase of Growth
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- Top Biotech Stocks: Exploring Innovation Opportunities
- The Best AI for Picking Stocks, Ranked by Performance
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.